Zobrazeno 1 - 10
of 20
pro vyhledávání: '"William N. William"'
Autor:
Boris Sepesi, Nicolas Zhou, William N. William, Heather Y. Lin, Cheuk H. Leung, Annikka Weissferdt, Kyle G. Mitchell, Apar Pataer, Garrett L. Walsh, David C. Rice, Jack A. Roth, Reza J. Mehran, Wayne L. Hofstetter, Mara B. Antonoff, Ravi Rajaram, Marcelo V. Negrao, Anne S. Tsao, Don L. Gibbons, J. Jack Lee, John V. Heymach, Ara A. Vaporciyan, Stephen G. Swisher, Tina Cascone
Publikováno v:
J Thorac Cardiovasc Surg
BACKGROUND: Surgical outcomes for non-small cell lung cancer after neoadjuvant immune checkpoint inhibitors continue to be debated. We assessed perioperative outcomes of patients treated with Nivolumab or Nivolumab plus Ipilimumab (NEOSTAR) and compa
Autor:
Richard P. Beckmann, Cathy Eng, David S. Hong, Howard A. Burris, Ricardo Martinez, Sameera R. Wijayawardana, Stefan C. Grant, Kathleen N. Moore, William N. William, Suzanne F. Jones, Funda Meric-Bernstam, Wei Zhang, Jeffrey R. Infante, Lisa Golden, Johanna C. Bendell, Manish R. Patel, Aimee Bence Lin
Publikováno v:
Clinical Cancer Research. 24:3263-3272
Purpose: Prexasertib, a checkpoint kinase 1 inhibitor, demonstrated single-agent activity in patients with advanced squamous cell carcinoma (SCC) in the dose-escalation portion of a phase I study (NCT01115790). Monotherapy prexasertib was further eva
Autor:
S. Andrew Peng, John V. Heymach, Lara Lacerda, Gustavo Schvartsman, J. Jack Lee, Marcelo F. Benveniste, Stephen G. Swisher, Emily Roarty, Frank V. Fossella, Jianjun Zhang, William N. William, Giorgios Bis
Publikováno v:
Lung Cancer. 112:90-95
Introduction Exploratory analysis of clinical trials in various tumor types have demonstrated potential improvements in overall response rate (ORR) to chemotherapy after exposure to vaccine-based immunotherapy. The objective of this retrospective stu
Autor:
Yeh Hung Yiin, Naifa L. Busaidy, William N. William, Stephen Y. Lai, Maria E. Cabanillas, Steven P. Weitzman, Laura Burke, Michelle D. Williams, Charles Lu, Anita K. Ying, G. Brandon Gunn
Publikováno v:
Head & Neck. 39:1291-1295
Background Anaplastic thyroid cancer (ATC) is a highly aggressive thyroid cancer. Several treatment trials are available, but the number of eligible patients to participate is very low because of the rarity and aggressiveness of the disease. Methods
Autor:
Xiuning, Le, Sonam, Puri, Marcelo V, Negrao, Monique B, Nilsson, Jacqulyne, Robichaux, Theresa, Boyle, J Kevin, Hicks, Katherine L, Lovinger, Emily, Roarty, Waree, Rinsurongkawong, Ming, Tang, Huiying, Sun, Yasir, Elamin, Lara C, Lacerda, Jeff, Lewis, Jack A, Roth, Stephen G, Swisher, J Jack, Lee, William N, William, Bonnie S, Glisson, Jianjun, Zhang, Vassiliki A, Papadimitrakopoulou, Jhanelle E, Gray, John V, Heymach
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research. 24(24)
Osimertinib was initially approved for T790M-positive non-small cell lung cancer (NSCLC) and, more recently, for first-line treatment ofUsing cohorts from The University of Texas MD Anderson Lung Cancer Moonshot GEMINI and Moffitt Cancer Center lung
Autor:
J. Jack Lee, Gypsyamber D'Souza, Dong M. Shin, Sungjin Kim, William N. William, Christine M. Komarck, Marina Mosunjac, Martin P. Graham, Robert L. Ferris, Heather M. Walline, Raja R. Seethala, Minh Ly Nguyen, David Sidransky, Emily Bellile, Lisa A. Peterson, Zhengjia Chen, Nabil F. Saba, Charles E. Moore, Hongzheng Zhang, Amy Y. Chen, Sara I. Pai, William H. Westra, Jennifer R. Grandis, Jonathan B. McHugh, Sreenivas Nannapaneni, Thomas E. Carey, Adel K. El-Naggar, Gabriel Sica, Zhuo Georgia Chen, James Riddell, Gregory T. Wolf
Background We examined the prognostic value of a panel of biomarkers in patients with squamous cell carcinoma of the head and neck (SCCHN) who were human immunodeficiency virus (HIV) positive (HIV-positive head and neck cancer) and HIV negative (HIV-
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fa486c2d6e8fdc9ae7dc543dbe53338e
https://europepmc.org/articles/PMC5808949/
https://europepmc.org/articles/PMC5808949/
Autor:
Christopher S. Hong, Zhiyuan Zhang, Weimin Ye, J. Jack Lee, Yan An Wang, Qiu Ming Yin, Wen Yong Tu, Yue He, Wei Guo, Yong-jie Hu, Han Guang Zhu, Chen Ping Zhang, W. Yang, Tong Ji, Jian Sun, Jun Li, Zhengping Zhuang, Guo Xin Ren, Zhong He Wang, Yi Li Cai, Li Qun Xu, Lai Ping Zhong, William N. William, Lizhen Wang, Jiang Li, Jeffrey N. Myers
Publikováno v:
Oncotarget
Previously, we conducted a randomized phase III trial of TPF (docetaxel, cisplatin, and 5-fluorouracil) induction chemotherapy in surgically managed locally advanced oral squamous cell carcinoma (OSCC) and found no improvement in overall survival. Th
Autor:
Abdallah S.R. Mohamed, Beth M. Beadle, Sean R. Quinlan-Davidson, William H. Morrison, Ann M. Gillenwater, Faye M. Johnson, William N. William, Heath D. Skinner, Steven J. Frank, Gary Brandon Gunn, David I. Rosenthal, Stephen Y. Lai, Clifton D. Fuller, Andrew J. Wong, Jeffrey N. Myers, Jack Phan, Adam S. Garden
Publikováno v:
Oral oncology. 72
Although treatment paradigms have not changed significantly, radiotherapy, surgery, and imaging techniques have improved, leading us to investigate oncologic and survival outcomes for oral cavity squamous cell cancer (OCSCC) patients treated with sur
Autor:
Bo Song Wang, Jian Sun, Lai Ping Zhong, Wei Guo, William N. William, Lizhen Wang, Wen Yong Tu, Jun Li, Yi Li Cai, Weimin Ye, Merrill S. Kies, Zhong He Wang, Jiang Li, W. Yang, Tong Ji, Zhiyuan Zhang, Li Qun Xu, Chen Ping Zhang, Guo Xin Ren, Yan An Wang, Yong-jie Hu, Yue He, J. Jack Lee, Han Guang Zhu, Xin Dong Fan, Jeffrey N. Myers
Publikováno v:
Journal of Clinical Oncology. 31:744-751
Purpose To evaluate induction chemotherapy with docetaxel, cisplatin, and fluorouracil (TPF) followed by surgery and postoperative radiotherapy versus up-front surgery and postoperative radiotherapy in patients with locally advanced resectable oral s
Autor:
Sean R, Quinlan-Davidson, William H, Morrison, Jeffrey N, Myers, Gary B, Gunn, William N, William, Beth M, Beadle, Heath D, Skinner, Ann M, Gillenwater, Steven J, Frank, Jack, Phan, Faye M, Johnson, Clifton D, Fuller, Mark E, Zafereo, David I, Rosenthal, Adam S, Garden
Publikováno v:
Headneck. 39(4)
We focused on a cohort of radiation naïve patients who had recurrent oral cavity cancer (recurrent OCC) to assess their outcomes with salvage multimodal therapy.A retrospective single institutional study was performed of patients with recurrent OCC.